Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer
This study has been completed.
Study NCT01439191   Information provided by Shanghai CP Guojian Pharmaceutical Co.,Ltd.

First Received on September 21, 2011.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metastatic Breast Cancer
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
humanized anti-HER2 antibody
Vinorelbine
Additional drug interventions recognized in this trial
Antibodies
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Shanghai CP Guojian Pharmaceutical Co.,Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services